FMS News and Press, Fresenius Medical Care AG From 03/05/19

The new CMS proposal Reuters published a long article titled " U.S. seeks to cut dialysis costs with more home care vs. clinics " that can be summarized as follows: The U.S. Centers for Medicare and Medicaid Services ((CMS)) "is looking at a trial payment design that would improve car...

February was a very turbulent month for me. Although the markets rallied strongly the earnings season, as always, has been a wild one and a painful one as well for a few stocks. On top of that, high-flying German fintech Wirecard (WCAGY) (WRCDF) completely collapsed following allegations about...

DaVita (NYSE: DVA ) ( -4% ) and Fresenius Medical Care (NYSE: FMS ) ( -3% ) are both in the red premarket in apparent response to the news that the Trump administration is working on a new payment approach for treating kidney disease patients that favors home care and transplants, a potent...

Editors' Note: This article is a transcript of our podcast on Davita Healthcare (DVA) which we published yesterday, where we spoke with Seeking Alpha reader Michael Knipp. We hope you find this transcript useful. Introduction Daniel Shvartsman: On this week’s Behind The Idea, ...

Fresenius Medical Care (NYSE: FMS ) has completed its $2B takeover of NxStage Medical. More news on: Fresenius Medical Care AG & Co. KGAA, Healthcare stocks news, Merger & acquisition news, Read more ...

WALTHAM, Mass. , Feb. 26, 2019 /PRNewswire/ -- Fresenius Medical Care, the world's largest provider of dialysis products and services, has successfully completed the acquisition of NxStage Medical, Inc. (NxStage), following approval by antitrust authorities in the United States . ...

Merger activity increased last week with four new deals announced and four pending deals closing. Deal Statistics: New Deals: The acquisition of Immune Design (IMDZ) by Merck (MRK) for $300 million or $5.85 per share in cash. The acquisition of Citizens First Corporation (C...

The following slide deck was published by Fresenius Medical Care AG & Co. KGAA in conjunction with their 2018 Q4 earnings Read more ...

Fresenius Medical Care ( FMS ) Q4 results (€): Revenues: 4,300M (-2.9%); Health Care Services: 3,413M (-4.7%); Health Care Products: 887M (+4.6%). More news on: Fresenius Medical Care AG & Co. KGAA, Healthcare stocks news, Earnings news and commentary, Stocks on the move, ...

Fresenius Medical Care (NYSE: FMS ): Q4 Non-GAAP EPS of €1.15; GAAP EPS of €1.38. More news on: Fresenius Medical Care AG & Co. KGAA, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...